| Jeffrey W Nix, MD | |
|
2000 6th Ave S, Birmingham, AL 35233-2110 | |
| (205) 945-0254 | |
| Not Available |
| Full Name | Jeffrey W Nix |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 18 Years |
| Location | 2000 6th Ave S, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215159843 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 32522 (Alabama) | Secondary |
| 390200000X | Student In An Organized Health Care Education/training Program | (* (Not Available)) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Alabama Hospital | Birmingham, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Alabama Health Services Foundation, Pc | 1951213107 | 2344 |
News Archive
Onyx Pharmaceuticals, Inc. today announced its plans to expand the Phase 3 European clinical trial FOCUS, which is evaluating the efficacy and tolerability of carfilzomib, a selective next-generation proteasome inhibitor.
Twenty-five year old Anna Luzania knows first-hand the effects of tobacco in the Hispanic Community. As a student at California State University (CSU) at Fresno, she did what many young people enjoying their first years of college do not - she took action to save the lives of her fellow students and community.
Research led by Dr. Suresh Alahari, Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, is the first to report that two specific tumor suppressor genes work in concert to inhibit the growth and spread of breast tumor cells to the lungs.
The tally continues to change regarding the governors who have said they will pursue the health law's Medicaid expansion. Most recently, Alaska Gov. Sean Parnell said he is opposed to it, while Pennsylvania Gov. Tom Corbett appears to be on the verge of reversing his position against the expansion. And, in Ohio, Gov. John Kasich is looking for allies to convince Republicans in the state legislature to follow his lead.
› Verified 4 days ago
| Entity Name | University Of Alabama Health Services Foundation, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093768723 PECOS PAC ID: 1951213107 Enrollment ID: O20031105000261 |
News Archive
Onyx Pharmaceuticals, Inc. today announced its plans to expand the Phase 3 European clinical trial FOCUS, which is evaluating the efficacy and tolerability of carfilzomib, a selective next-generation proteasome inhibitor.
Twenty-five year old Anna Luzania knows first-hand the effects of tobacco in the Hispanic Community. As a student at California State University (CSU) at Fresno, she did what many young people enjoying their first years of college do not - she took action to save the lives of her fellow students and community.
Research led by Dr. Suresh Alahari, Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, is the first to report that two specific tumor suppressor genes work in concert to inhibit the growth and spread of breast tumor cells to the lungs.
The tally continues to change regarding the governors who have said they will pursue the health law's Medicaid expansion. Most recently, Alaska Gov. Sean Parnell said he is opposed to it, while Pennsylvania Gov. Tom Corbett appears to be on the verge of reversing his position against the expansion. And, in Ohio, Gov. John Kasich is looking for allies to convince Republicans in the state legislature to follow his lead.
› Verified 4 days ago
| Entity Name | Health Care Authority For Baptist Health, An Affiliate Of Uabhs |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982653390 PECOS PAC ID: 8426076670 Enrollment ID: O20060220000538 |
News Archive
Onyx Pharmaceuticals, Inc. today announced its plans to expand the Phase 3 European clinical trial FOCUS, which is evaluating the efficacy and tolerability of carfilzomib, a selective next-generation proteasome inhibitor.
Twenty-five year old Anna Luzania knows first-hand the effects of tobacco in the Hispanic Community. As a student at California State University (CSU) at Fresno, she did what many young people enjoying their first years of college do not - she took action to save the lives of her fellow students and community.
Research led by Dr. Suresh Alahari, Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, is the first to report that two specific tumor suppressor genes work in concert to inhibit the growth and spread of breast tumor cells to the lungs.
The tally continues to change regarding the governors who have said they will pursue the health law's Medicaid expansion. Most recently, Alaska Gov. Sean Parnell said he is opposed to it, while Pennsylvania Gov. Tom Corbett appears to be on the verge of reversing his position against the expansion. And, in Ohio, Gov. John Kasich is looking for allies to convince Republicans in the state legislature to follow his lead.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey W Nix, MD Po Box 55310, Birmingham, AL 35255-5310 Ph: () - | Jeffrey W Nix, MD 2000 6th Ave S, Birmingham, AL 35233-2110 Ph: (205) 945-0254 |
News Archive
Onyx Pharmaceuticals, Inc. today announced its plans to expand the Phase 3 European clinical trial FOCUS, which is evaluating the efficacy and tolerability of carfilzomib, a selective next-generation proteasome inhibitor.
Twenty-five year old Anna Luzania knows first-hand the effects of tobacco in the Hispanic Community. As a student at California State University (CSU) at Fresno, she did what many young people enjoying their first years of college do not - she took action to save the lives of her fellow students and community.
Research led by Dr. Suresh Alahari, Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, is the first to report that two specific tumor suppressor genes work in concert to inhibit the growth and spread of breast tumor cells to the lungs.
The tally continues to change regarding the governors who have said they will pursue the health law's Medicaid expansion. Most recently, Alaska Gov. Sean Parnell said he is opposed to it, while Pennsylvania Gov. Tom Corbett appears to be on the verge of reversing his position against the expansion. And, in Ohio, Gov. John Kasich is looking for allies to convince Republicans in the state legislature to follow his lead.
› Verified 4 days ago